Hainan Honz Pharmaceutical Co Cash Flow Reinvestment Rate
Hainan Honz Pharmaceutical Co cash flow reinvestment rate. Hainan Honz Pharmaceutical Co (300086) has a Cash Flow Reinvestment Rate of 0.39x as of June 2025, reinvesting CN¥9.99 Million (capex CN¥4.99 Million plus investments CN¥-4.99 Million) from operating cash flow of CN¥25.84 Million. Explore debt repayment capacity of Hainan Honz Pharmaceutical Co to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hainan Honz Pharmaceutical Co (2007–2025)
Cash flow reinvestment rate of Hainan Honz Pharmaceutical Co from 2007 to 2025. Historical reinvestment intensity for Hainan Honz Pharmaceutical Co across 17 annual periods. Explore Hainan Honz Pharmaceutical Co (300086) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hainan Honz Pharmaceutical Co Cash Flow Reinvestment Rate by Year (2007–2025)
Hainan Honz Pharmaceutical Co cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Hainan Honz Pharmaceutical Co. For the full cash flow conversion analysis, see Hainan Honz Pharmaceutical Co (300086) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.76x | CN¥92.12 Million | CN¥121.24 Million | CN¥92.12 Million | ▼ -69.2% |
| 2024 | 2.47x | CN¥176.42 Million | CN¥71.46 Million | CN¥92.50 Million | ▼ -11.4% |
| 2023 | 2.79x | CN¥197.04 Million | CN¥70.69 Million | CN¥137.56 Million | ▲ +39.7% |
| 2022 | 1.99x | CN¥58.48 Million | CN¥29.32 Million | CN¥45.10 Million | ▼ -90.9% |
| 2021 | 21.80x | CN¥246.97 Million | CN¥11.33 Million | CN¥219.97 Million | ▲ +315.1% |
| 2019 | 5.25x | CN¥236.65 Million | CN¥45.06 Million | CN¥130.99 Million | ▼ -28.3% |
| 2018 | 7.33x | CN¥1.16 Billion | CN¥157.66 Million | CN¥291.68 Million | ▼ -31.5% |
| 2017 | 10.70x | CN¥194.45 Million | CN¥18.17 Million | CN¥152.85 Million | ▲ +358.2% |
| 2016 | 2.34x | CN¥212.26 Million | CN¥90.88 Million | CN¥41.57 Million | ▲ +224.3% |
| 2015 | 0.72x | CN¥56.39 Million | CN¥78.30 Million | CN¥56.39 Million | ▲ +71.5% |
| 2014 | 0.42x | CN¥31.04 Million | CN¥73.93 Million | CN¥31.04 Million | ▼ -41.4% |
| 2013 | 0.72x | CN¥56.55 Million | CN¥78.93 Million | CN¥56.55 Million | ▲ +54.4% |
| 2012 | 0.46x | CN¥50.81 Million | CN¥109.46 Million | CN¥50.81 Million | ▼ -67.7% |
| 2010 | 1.44x | CN¥114.90 Million | CN¥79.89 Million | CN¥114.90 Million | ▲ +117.6% |
| 2009 | 0.66x | CN¥61.85 Million | CN¥93.58 Million | CN¥61.85 Million | ▲ +21.3% |
| 2008 | 0.54x | CN¥34.10 Million | CN¥62.61 Million | CN¥34.10 Million | ▼ -18.0% |
| 2007 | 0.66x | CN¥20.33 Million | CN¥30.59 Million | CN¥20.33 Million | — |